Analyst Ratings for Alpha Tau Medical
Portfolio Pulse from Benzinga Insights
Alpha Tau Medical (NASDAQ:DRTS) has received 4 analyst ratings in the last quarter, with an average 12-month price target of $12.25, a high of $23.00, and a low of $8.00. The current average price target represents a 2.08% increase from the previous target of $12.00. The ratings consist of 2 bullish and 2 somewhat bullish, with no indifferent, somewhat bearish, or bearish ratings.
November 17, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alpha Tau Medical has a favorable analyst outlook with an average 12-month price target of $12.25, reflecting a 2.08% increase from the previous target.
The positive analyst ratings and the increase in the average price target suggest a bullish sentiment towards DRTS. This could lead to increased investor confidence and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100